ARCHIVES

Thyroid Cancer Briefing Planned

This article is from The Cancer Letter archive.

Vol. 03 No. 27 | July 8, 1977

Download PDF Visit The Full Archive

Related Articles

Top Management Shifts At Bristol-Myers Squibb Oncology, R&D Units

October 6, 1995

ODAC Prefers Three-Hour Taxol Infusion. Says Data Dosage Still Uncertain

October 1, 1993

Former BMS Executive Bodnar Indicted.

April 25, 2008

NCAB Settles New Touchy PDQ Issues

June 7, 1985

St. John’s Wort Not Indicated For Patients On Irinotecan

May 31, 2002

Cancer Center Lineup complete: 11 Renewals, Funding Continued for Three, Two Unfunded

September 28, 1990